TSS
HUMAW

Two Sigma Securities’s Humacyte Inc Warrant HUMAW Stock Holding History

Two Sigma Securities’s Portfolio HUMAW Stock Details HUMAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$403 Sell
42,019
-105
-0.2% -$7 ﹤0.01% 1648
2026
Q1 		$3.85K Sell
42,124
-3,218
-7% -$368 ﹤0.01% 1530
2025
Q4 		$4.25K Buy
+45,342
New +$8.67K ﹤0.01% 1348

Other funds holding HUMAW

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Two Sigma Securities's HUMAW Position: Q2 2026 in Review

Two Sigma Securities reduced its Humacyte Inc Warrant (HUMAW) stake by 0.25% in Q2 2026, selling an estimated $7 and leaving 42,019 shares worth $403. The position accounts for ﹤0.01% of the portfolio, ranked #1648.

Two Sigma Securities first reported a position in HUMAW in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.25K in Q4 2025. 8 funds tracked by Wall St. Rank hold HUMAW as of Q2 2026.

  • Two Sigma Securities held 42,019 shares of Humacyte Inc Warrant worth $403 as of Q2 2026.
  • Two Sigma Securities sold 105 Humacyte Inc Warrant shares in Q2 2026, an estimated $7.
  • Humacyte Inc Warrant made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1648 holding.
  • Two Sigma Securities first reported a position in Humacyte Inc Warrant in Q4 2025 and has held it in 3 quarters since.
  • Two Sigma Securities's Humacyte Inc Warrant position peaked at $4.25K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.